leucogen

DRUG2 trials

Sponsors

Sun Yat-sen University, Fudan University

Conditions

ChemotherapyLeucogenMyelosuppressionNasopharyngeal CarcinomaNon-small Cell Lung CancerPralsetinibRET Fusion

Phase 3

A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC

Not yet recruitingNCT05780294

Sun Yat-sen UniversityChemotherapy, Leucogen, Myelosuppression +1

Start: 2023-04-01End: 2029-12-01Target: 132Updated: 2023-03-22

Unknown Phase

A Real-world Study of Pralsetinib Combined With Leucogen in the Treatment of RET Fusion-positive NSCLC

Not yet recruitingNCT07418879

Fudan UniversityNon-small Cell Lung Cancer, Pralsetinib, RET Fusion

Start: 2026-02-05End: 2028-12-31Target: 25Updated: 2026-02-18